Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Times Interest Earned (2021 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Times Interest Earned for 9 consecutive years, with -$0.32 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 93.64% year-over-year to -$0.32, compared with a TTM value of -$1.7 through Sep 2025, down 506.35%, and an annual FY2024 reading of $0.63, up 116.77% over the prior year.
  • Times Interest Earned was -$0.32 for Q3 2025 at Fennec Pharmaceuticals, up from -$4.6 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $81.82 in Q3 2021 and bottomed at -$1230.8 in Q1 2021.
  • Average Times Interest Earned over 5 years is -$104.48, with a median of -$4.71 recorded in 2024.
  • Peak annual rise in Times Interest Earned hit 301.26% in 2024, while the deepest fall reached 327.17% in 2024.
  • Year by year, Times Interest Earned stood at $81.82 in 2021, then tumbled by 108.2% to -$6.71 in 2022, then soared by 70.4% to -$1.99 in 2023, then skyrocketed by 51.34% to -$0.97 in 2024, then skyrocketed by 66.64% to -$0.32 in 2025.
  • Business Quant data shows Times Interest Earned for FENC at -$0.32 in Q3 2025, -$4.6 in Q2 2025, and -$1.36 in Q1 2025.